Prestige Consumer Healthcare (PBH) Income from Continuing Operations (2010 - 2025)

Prestige Consumer Healthcare's (PBH) quarterly Income from Continuing Operations came in at 46696000.0 in Q4 2025, down 23.49% year-on-year from 61032000.0 in Q4 2024, and up 10.63% quarter-over-quarter from 42211000.0 in Q3 2025.

Prestige Consumer Healthcare (PBH) Income from Continuing Operations (2010 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Income from Continuing Operations history runs 16 years deep, the most recent figure standing at 46696000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 23.49% year-over-year to 46696000.0 in Q4 2025; TTM through Dec 2025 was 186501000.0, a 12.82% decrease from a year earlier, with the FY2025 full-year figure at 214605000.0, up 2.52% from the prior year.
  • Income from Continuing Operations grew to 46696000.0 in Q4 2025 per PBH's latest filing, from 42211000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 61032000.0 in Q4 2024 and bottomed at 240552000.0 in Q1 2023.
  • The 5-year median for Income from Continuing Operations is 50619000.0 (2021), against an average of 35945300.0.
  • Across the five-year window, Income from Continuing Operations plunged 561.84% in 2023 and surged 120.56% in 2024, its largest moves.
  • Year by year, Income from Continuing Operations stood at 50215000.0 in 2021, then increased by 3.46% to 51951000.0 in 2022, then grew by 2.11% to 53046000.0 in 2023, then grew by 15.05% to 61032000.0 in 2024, then dropped by 23.49% to 46696000.0 in 2025.
  • Per Business Quant, the three latest PBH Income from Continuing Operations figures stand at 46696000.0 (Q4 2025), 42211000.0 (Q3 2025), and 47466000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 370.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -3.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 274.90 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 Prestige Consumer Healthcare 2.34 Bn 2.28 Bn 157.37 Mn 46.70 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 46.70 Mn
Sep 30, 2025 42.21 Mn
Jun 30, 2025 47.47 Mn
Mar 31, 2025 50.13 Mn
Dec 31, 2024 61.03 Mn
Sep 30, 2024 54.38 Mn
Jun 30, 2024 49.07 Mn
Mar 31, 2024 49.46 Mn
Dec 31, 2023 53.05 Mn
Sep 30, 2023 53.56 Mn
Jun 30, 2023 53.28 Mn
Mar 31, 2023 -240.55 Mn
Dec 31, 2022 51.95 Mn
Sep 30, 2022 51.02 Mn
Jun 30, 2022 55.27 Mn
Mar 31, 2022 52.09 Mn
Dec 31, 2021 50.22 Mn
Sep 30, 2021 45.33 Mn
Jun 30, 2021 57.76 Mn
Mar 31, 2021 35.51 Mn